In 3xTg-AD triple mutant mice (which harbor mutations in PS-1, APP and tau) and in the brains of human patients with AD, the levels of NCLX are reduced, leading to an increase in mCa2+ concentration (Table 1). The gene discussed is APP; the disease is Alzheimer disease.